Classifications

• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
  • C12N9/0004—Oxidoreductases (1.)
  • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
  • C12N9/0073—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Y—ENZYMES
  • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
  • C12Y114/13—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen (1.14.13)
  • C12Y114/13016—Cyclopentanone monooxygenase (1.14.13.16)

Definitions

• the present invention relates to an isolated DNA encoding a cyclopentanone monooxygenase (CPMO), or an enzymatically active portion thereof, and expression vector and a transformed cell containing the isolates DNA.
• CPMO cyclopentanone monooxygenase
• NCIMB 9872 was one of the few microorganisms that have been characterized to produce a Baeyer-Villiger monooxygenase (BVMO; Griffin, M., et al., Biochem. J. 129:595-603, 1972; Griffin, M., et al., Eur. J. Biochem. 63:199-209, 1976; and Willetts, A., Trends in Biotech. 15:55-62, 1997; for a recent review).
• BVMO Baeyer-Villiger monooxygenase
• BVMOs are flavoproteins that mimic the classical Baeyer-Villiger organic chemical reaction which is a peracid- catalyzed oxidation of a ketone to an ester or lactone.
• the use of enzyme substitutes for the production of lactones in high yield and optical purity is an attractive feature in current trends of research and development toward replacing chemical methods with biological alternatives (Stinson, S.C., Chem. Eng. News, 83-104, 1998).
• the best characterized BVMO enzyme is that of cyclohexanone monooxygenase (CHMO) produced by Acinetobacter sp. NCIMB 9871 (Stewart, J.D., Curr. Org. Chem.
• One aim of the present invention is to provide a new CPMO having an increased enzymatic activity for growing cells in a medium containing cyclopentanol or cyclopentanone as sole carbon source.
• DNA encoding a cyclopentanone monooxygenase (CPMO), or an enzymatically active portion thereof, the isolated DNA being characterized by the ability to hybridize specifically with the complement of the DNA represented in SEQ ID NO:8 under stringent hybridization conditions.
• CPMO cyclopentanone monooxygenase
• CPMO cyclopentanone monooxygenase
• an isolated DNA encoding a cyclopentanone monooxygenase (CPMO), or an enzymatically active portion thereof, said isolated DNA having SEQ ID NO:8.
• CPMO cyclopentanone monooxygenase
• the present invention further provides an isolated DNA expression vector encoding an enzymatically active cyclopentanone monooxygenase (CPMO) comprising a DNA characterized by a sequence as set forth in SEQ ID NO:8, or a portion thereof, said portion encoding said CPMO, in expressible form.
• CPMO cyclopentanone monooxygenase
• a recombinant vector comprising the isolated DNA as decribed above, wherein the isolated DNA encodes cyclopentanone monooxygenase.
• the isolated DNA has a nucleic acid sequence of SEQ ID NO:8 or which, due to the degeneracy of the genetic code, is a functional equivalent thereof.
• a recombinant vector containing one or more copies of a recombinant DNA described above .
• the recombinant vector may be a prokaryotic vector.
• the recombinant vector may also be a plasmid.
• a biologically functional plasmid or viral DNA vector which contains a DNA as described above.
• the present invention also provide a host cell comprising a recombinant vector as described above .
• a cell transformed with a heterologous DNA expression construct encoding an enzymatically active cyclopentanone monooxygenase (CPMO) comprising a DNA characterized by a sequence as set forth in SEQ ID NO:8, or a portion thereof, said portion encoding said CPMO
• the cell may be a prokaryotic cell or it may be E. coli.
• CPMO cyclopentanone monooxygenase
• the present invention also provides a recombinant cyclopentanone monooxygenase (CPMO) having an enzymatic activity superior to the one from a native Pseudomonas, and more preferably twice superior.
• CPMO cyclopentanone monooxygenase
• the recombinant cyclopentanone monooxygenase may be prepared from Comamonas sp. NCIMB 9872.
• the recombinant cyclopentanone monooxygenase has preferably a sequence as set forth in SEQ ID NO:5.
• a method for growing cells in vitro in presence of cyclopentanol or cyclopentanone as sole source of carbon comprising the steps of:
• step a) transforming a cell with the expression construct described above; and b) growing the cell of step a) under suitable conditions in a medium containing cyclopentanol or cyclopentanone as a sole source of carbon.
• Fig. 1 illustrates the first two steps of cyclopentanol degradation by Pseudomonas sp. NCIMB 9872;
• Fig. 2 illustrates the genetic organization in Comamonas sp. NCIMB 9872 in the Sph ⁇ fragment containing cyclopentanone monooxygenase- encoding gene ⁇ cpnB) and additional open reading frames;
• Fig. 3 illustrates an alignment of the amino acid sequence of the CPMO of Comamonas sp. NCIMB 9872 with that of CHMO from Acinetobacter sp. NCIMB 9871 and a steroid monooxygenase (STMO) from Rhodococcus rhodochrous;
• Fig. 4 illustrates a SDS-PAGE of crude extracts from E. coli (pCMP201 ).
• Fig. 5 illustrates CPMO-encoding gene, designated cpnB.
• NCIMB 9872 (henceforth strain 9872) identified as a Comamonas by 16S rDNA sequencing in this study, was purchased from the National Collections of Industrial and Marine Bacteria Ltd (NCIMB, Aberdeen, Scotland) and grown at 30°C in Luria-Bertani (LB) broth (Sambrook, J., et al., Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y, 1989), or mineral salt medium (MSM), pH 7.0, containing 2 ml of cyclopentanone.
• LB Luria-Bertani broth
• MSM mineral salt medium
• the MSM recipe contains per liter: 1.0 g of NH 4 NO 3 , 1.5 g of KH 2 P0 4 , 1.5 g of Na 2 HP0 4 , 0.2 g MgSO 4 « 7H 2 0, 0.01 g of CaCI 2 « 2H 2 0, 0.005 of FeSO « 7H 2 0, 0.002 g of MnS0 4 « 4H 2 0 and 0.1 g of yeast extract. Agar was added to 1.5% for plates. Genomic DNA of strain 9872 was prepared by the Marmur method (Marmur, J., J. Mol. Biol. 3: 208-218, 1961).
• the PCR amplification was performed in a Perkin Elmer-Model 2400 Thermal CyclerTM and the amplification conditions were 94°C for 1 min, 50°C for 1 min and 72°C for 1 min for 30 cycles.
• the amplified product was cloned directly in the pXcmkn12 vector (Cha, J., et al., Gene 136, 369-370, 1993), transformed in E. coli JM109 and the resulting plasmid was designated pCMP10. Before using the amplified product as a gene probe its nucleotide sequence was confirmed. Nucleotide sequencing was determined by the Taq DyeDeoxy terminator cycle sequencing kit and the ABI Prism 310 Genetic Analyzer (Perkin Elmer). Plasmid isolation was performed by the method of Birnboim and Doly (Birnboim, H. C, and J. Doly, DNA. Nucleic Acids Res. 7:1513-1523, 1979).
• Orf1 is most likely a transcriptional activator of the NtrC-type (Morett, E., L. Segovia, J. Bacteriol. 175:6067-6074, 1993).
• the amino acid sequence of ORF1 (C-terminal 391 -amino acids) showed 38-40% identity to equivalent regions of proteins such as NTRCJ ⁇ COLI (Nitrogen regulation protein NR(I) from E.
• ORF2 The amino acid sequence of ORF2, showing similarity to enzymes of the short-chain alcohol dehydrogenase family (Jornvall, H., et al., Biochemistry 34: 6003-6013, 1995), is most homologous (45-46% identity) to a putative oxidoreductase CY39.16C of Mycobacterium tuberculosis (Swiss Prot sp:Q10855) and fadG3 of M. tuberculosis (GenBank accession number Z74025). For Pseudomonas sp.
• strain HI-201 the /acZ-Km r cassette from pKOK6.1 (Kokotek, W., et al., Gene 84: 467-471 , 1989) was inserted into cpnB at the ⁇ fe/ ' l site.
• t ⁇ transcriptional termination sequence of phage fd
• Km r kanamycin resistance gene
• lacZ gene encoding b-galactosidase. Genes and markers are indicated with arrows.
• the DNA insert from pCMPIO was amplified, labeled by the digoxigenin-11-UTP system according to manufacturer's instructions (Boehringer Mannheim GmbH) and used to probe a Southern hybridization of strain 9872 genomic DNA digested with various restriction enzymes ( ⁇ amHI, EcoRI, /-// ⁇ dlll, Kpn ⁇ , Nhe ⁇ , Pst ⁇ , Sal ⁇ , Sph ⁇ and Xba ⁇ ). As a result, a single hybridizing band of ca 4.3-kb Sph ⁇ fragment was obtained. Conditions of hybridization were as before.
• Nucleotide sequencing of the CPMO-encoding gene was initiated by using a primer designed from the sequence of the PCR product cloned in pCMPIO and further extended using oligonucleotides derived from the new sequence. Both DNA strands of the Sph ⁇ fragment were sequenced and found to consist of 4281 base pairs (bp). The sequence was analyzed by GENETYX- Mac (Software Development Co., Ltd. Chiba, Japan) and the BLAST program (Altschul, S. F., et al., Nucleic Acids Res. 25:3389-3402, 1997). As a result three open reading frames (ORFs) arranged in the same direction were predicted (Fig. 2).
• the nucleotide sequence of the 1650-bp ORF encoding CPMO is preceded by a partial ORF1 (1173-bp) coding for the C-terminus of an NtrC-type transcriptional activator (Miranda, et al., The complete nucleotide sequence of the glnALG operon of Eschericha coli K12 15:2757-2770, 1987) and by a complete ORF2 (750-bp) coding for a homolog of the short-chain dehydrogenases/reductases (Jornvall, H., et al., Biochemistry 34: 6003-6013, 1995). The two intergenic regions are 244-bp and 32-bp, respectively.
• the CPMO-encoding gene is referred to cpnB (cyclopentanone and ⁇ designates the second step of the degradation pathway, see Fig. 1) hereafter.
• cpnB cyclopentanone and ⁇ designates the second step of the degradation pathway, see Fig. 1 hereafter.
• the CPMO-encoding gene starts at nucleotide position 1822 and ends 3471 that does not include the stop codon. Accordingly, the boundary of cpnA is 3507- 4256.
• the partial open reading frame preceding cpnB is from 1-1174.
• Fig. 1 has been adapted from Griffin, M., et al. (Griffin, M., et al., Biochem. J. 129:595-603, 1972).
• the designated genes are: cpnA encoding cyclopentanol dehydrogenase; cpnB encoding cyclopentanone 1 ,2- monooxygenase (CPMO).
• An alternative name for 5-valerolactone is 5- pentanolide.
• Subsequent reaction steps are the formation of 5-hydroxyvalerate, 5-oxovalerate, glutarate and finally acetyl CoA.
• the amino acid sequence of the CPMO enzyme consists of 550 residues (Fig. 3). This sequence shows 36.5% identity and an additional 13.6% amino acid similarity with the 543-residue CHMO of Acinetobacter sp. strain NCIMB 9871.
• An equally related protein (549 amino acids; 37.3% identity and 12.4% similarity) is the putative steroid monooxygenase (STMO) of Rhodococcus rhodochrous (Morii, S., et al., GenBank accession number AB010439, 1998).
• STMO putative steroid monooxygenase
• Rhodococcus rhodochrous Rhodococcus rhodochrous
• the latter enzyme carries out the oxidation of progesterone to produce testosterone acetate.
• a CLUSTAL alignment of these three sequences gave 24.6% positional identity (Fig. 3).
• asterisks indicate identical amino acids, dots indicated similar amino acids and dashes indicate gaps introduced to maximize the alignment.
• the amino-terminal peptide sequence confirmed by Edman degradation is underlined.
• the locations of the consensus FAD fingerprint sequences as described by Eppink et al. (Eppink, et al., Prot. Sci. 6:2454-2458, 1997) are as indicated.
• the conserved GD motif found in flavoprotein hydroxylases as a second FAD fingerprint is also indicated.
• the DG motif of flavoprotein hydroxylases which has the sequence of chhhssDGxcSxhR. Lower case letters identify certain residues types: h, hydrophobic residues, s, small residues, c, charged residues, and x, any residues. Note that a DG doublet is present in CPMO and STMO sequence.
• Flavoprotein hydroxylases eg. phenol hydroxylase, the structure is now known; Enroth, C, et al., Structure 6:605-617, 1998) are monooxygenases that catalyze the insertion of one atom of molecular oxygen into the substrate using NAD(P)H as electron donor.
• Plasmid pSD80 is a third generation derivative of the commercially available pKK223-3 vector (Pharmacia) that contains a tac promoter upstream of the multiple cloning site (MCS), an unc terminator sequence downstream of the MCS, and lacl q elsewhere on the plasmid (Smith, S.P., et al., Biochemistry 35:8805-8814, 1996).
• the primers were: 5'-
• AAAAGGCCTG AACTTCAATT ATTTAGGAGA C-3' (SEQ ID NO:3) and 5'- AAAACTGCAG GAGTTGCACA ACAGAGTCTT AG-3' with built-in Stu ⁇ and Pst ⁇ restriction sites (underlined), respectively, to facilitate cloning at the compatible sites (Smal and Pst ⁇ ) of the pSD80 vector.
• Vent DNA polymerase New England BioLabs, Beverly, MA
• the amplified DNA fragment was purified from an agarose gel and digested with Stu ⁇ and Pst ⁇ .
• pCMP201 One of the resulting recombinant plasmids was designated pCMP201.
• Fig. 4 shows the production of a 60-kDa protein in a Coomassie blue- stained SDS-polyacrylamide gel of the crude protein extract prepared from E. coli JM109 (pCMP201) cells that were induced by 0.1 mM isopropyl-beta-D- thiogalactopyranoside (IPTG). The cells were induced at an absorbance (A600 5 nm) of 0.4 to 0.5 and the induction period was up to 4 hr.
• CPMO activity was assayed at 25°C by measuring a decrease in 0 absorbance at 340 nm in 50 mM phosphate buffer (pH 7.8) containing 1 ⁇ mol of cyclopentanone, 0.2 ⁇ mol of NADPH, and the crude enzyme extract prepared from E. coli JM109 (pCMP201 ). These cells were cultivated in 100 ml of LB medium containing 100 ⁇ g/ml of ampicillin at 25°C.
• IPTG-induced cells were harvested by centrifugation, washed in 50 mM phosphate buffer (pH 7.2), 5 resuspended in 1/20 volume of same buffer, and sonicated by four-20 sec bursts with a Braun-SonifierTM 250 apparatus. After centrifugation for 30 min at 18,000 x g and at 4°C, the supernatant was used for determination of enzyme activity.
• U One unit (U) of activity is defined as the amount of enzyme required to convert 1 ⁇ mol of substrate in 1 min. Protein concentration was determined by o the method of Bradford (Bradford, M. M., Anal. Biochem. 72: 248-254, 1976).
• the specific activity of the CPMO enzyme was found to be 0.28 U/mg.
• the specific activity of CPMO in the native Pseudomonas was reported to be 0.11 U/mg (Griffin, M., et al., Biochem. J. 129:595-603, 1972).
• lane 1 has been loaded with extracts of IPTG-induced E. coli 5 and lane 2 has been loaded with extracts of E. coli in absence of IPTG.
• M means molecular weight markers as indicated in kilo daltons. The arrow indicates the production of the desired 60-kDa protein.
• Pseudomonas sp. strain HI-201 was constructed by chromosomal o inactivation of the cpnB gene using a /acZ-Km r cassette from the mobilizable pKOK6.1 vector (Kokotek, W., et al., Gene 84: 467-471 , 1989).
• pKOK6.1 the lacZ gene is promoterless and in addition to Km r it is ampicillin resistant (Ap r ).
• the /acZ-Km r cassette was excised as a Psfl-fragment and inserted into the Nsi ⁇ site within the cpnB gene in pCMP200, yielding pCMP202.
• Electroporation of this plasmid into 9872 cells was carried out in the Gene PulserTM (BioRads) and the parameters of electroporation were 2.5 kV, 25 uF and 200 ohm.
• the cells were initially washed with 1mM HEPES buffer and resuspended in 1 mM HEPES containing 10% glycerol.
• Km r colonies were selected on LB plates containing Km (250 ⁇ g/ml).
• a second screening on LB plates containing Ap 300 ⁇ g /ml) was carried out.
• the inactivation of cpnB (Fig. 2), was confirmed by PCR.
• the amino acid sequence of CPMO contains motifs of FAD fingerprints similar to those found in flavoprotein hydroxylases.

Landscapes

• Chemical & Material Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• Zoology (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Genetics & Genomics (AREA)
• Wood Science & Technology (AREA)
• General Health & Medical Sciences (AREA)
• General Engineering & Computer Science (AREA)
• Biochemistry (AREA)
• Molecular Biology (AREA)
• Microbiology (AREA)
• Biotechnology (AREA)
• Biomedical Technology (AREA)
• Medicinal Chemistry (AREA)
• Enzymes And Modification Thereof (AREA)
• Micro-Organisms Or Cultivation Processes Thereof (AREA)

Priority Applications (6)

Applications Claiming Priority (2)

Related Child Applications (2)

Publications (2)

Family

ID=22816718

Family Applications (1)

Country Status (6)

Cited By (2)

Families Citing this family (3)

Family Cites Families (34)

• 2001
  • 2001-07-13 CA CA002418155A patent/CA2418155A1/en not_active Abandoned
  • 2001-07-13 WO PCT/CA2001/001032 patent/WO2002006452A2/en not_active Ceased
  • 2001-07-13 EP EP01953719A patent/EP1303614A2/en not_active Withdrawn
  • 2001-07-13 JP JP2002512345A patent/JP2004504025A/ja active Pending
  • 2001-07-13 US US10/312,585 patent/US7214520B2/en not_active Expired - Fee Related
  • 2001-07-13 AU AU2001276210A patent/AU2001276210A1/en not_active Abandoned
• 2007
  • 2007-03-28 US US11/727,730 patent/US7541168B2/en not_active Expired - Fee Related

Non-Patent Citations (5)

Also Published As

Similar Documents

Legal Events